i-manager Publications

A Review on Rotavirus Infection

Rincy R. L.*, Aneeta Toms**

*-** The Dale View College of Pharmacy and Research Centre, Poovachal, Thiruvananthapuram, Kerala, India.

Periodicity:January - June'2024

Abstract

Rotaviruses are the most common cause of diarrheal disease among infants and young children. Nearly every child in the world is infected with a rotavirus at least once by the age of five. Immunity develops with each infection, so subsequent infections are less severe. Adults are rarely affected. The most common symptoms of rotavirus infection are severe watery diarrhea, vomiting, fever, and/or abdominal pain. Symptoms usually start about two days after exposure to rotavirus. Vomiting and watery diarrhea can last for three to eight days. There is no specific medicine to treat rotavirus infection. Since rotavirus disease can cause severe vomiting and diarrhea, it can lead to dehydration.

Keywords

Rotavirus, Diarrhea, Vaccination, Rotavirus, Gastroenteritis, Viral Diarrhea, Vaccination, Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis.

How to Cite this Article?

Rincy, R. L., and Toms, A. (2024). A Review on Rotavirus Infection. Dale View's Journal of Clinical Pharmacology and Pharmacotherapeutics, 1(1), 1-7.

References

[1]. Aballéa, S., Millier, A., Quilici, S., Caroll, S., Petrou, S., & Toumi, M. (2013). A critical literature review of health economic evaluations of rotavirus vaccination. Human Vaccines & Immunotherapeutics, 9(6), 1272-1288.

[2]. Aliabadi, N., Tate, J. E., Haynes, A. K., & Parashar, U. D. (2015). Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination- United States, 2000-2014. MMWR Morb Mortal Wkly Rep, 64(13), 337-42.

[3]. Anderson, E. J., & Weber, S. G. (2004). Rotavirus infection in adults. The Lancet Infectious Diseases, 4(2), 91-99.

[4]. Atherly, D. E., Lewis, K. D., Tate, J., Parashar, U. D., & Rheingans, R. D. (2012). Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030. Vaccine, 30, A7-A14.

[5]. Bhaumik, S. (2013). Rotavirus vaccine in India faces controversy. Canadian Medical Association Journal, 185(12), E563.

[6]. Burnett, E., Parashar, U., & Tate, J. (2018). Rotavirus vaccines: Effectiveness, safety, and future directions. Pediatric Drugs, 20, 223-233.

[7]. Cook, S. M., Glass, R. I., LeBaron, C. W., & Ho, M. S. (1990). Global seasonality of rotavirus infections. Bulletin of the World Health Organization, 68(2), 171.

[8]. Crawford, S. E., Ramani, S., Tate, J. E., Parashar, U. D., Svensson, L., Hagbom, M., Franco, M. A., O'Ryan, M., Greenberg, H. B., Kang, G., Desselberger, U., & Estes, M. K. (2017). Rotavirus infection. Nature Reviews Disease Primers, 3(1), 1-16.

[9]. Dennehy, P. H. (2008). Rotavirus vaccines: An overview. Clinical Microbiology Reviews, 21(1), 198-208.

[10]. Domingo, J. D., Patrzalek, M., Cantarutti, L., Arnould, B., Meunier, J., Soriano-Gabarro, M., Meyer, N., Pirçon, J. Y., & Holl, K. (2012). The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: Prospective observational study in European primary care medical practices. BMC Pediatrics, 12, 1-8.

[11]. Griebsch, I., Coast, J., & Brown, J. (2005). Quality- adjusted life-years lack quality in pediatric care: A critical review of published cost-utility studies in child health. Pediatrics, 115(5), e600-e614.

[12]. Jiang, L., Tang, A., Song, L., Tong, Y., & Fan, H. (2023). Advances in the development of antivirals for rotavirus infection. Frontiers in Immunology, 14, 1041149.

[13]. Kumar, C. G., Giri, S., Chawla-Sarkar, M., Gopalkrishna, V., Chitambar, S. D., Ray, P., ... & Mehendale, S. M. (2020). Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India. Vaccine, 38(51), 8154-8160.

[14]. Malik, A., Haldar, P., Ray, A., Shet, A., Kapuria, B., Bhadana, S., Santosham, M., Ghosh, R. S., Steinglass, R., & Kumar, R. (2019). Introducing rotavirus vaccine in the Universal Immunization Programme in India: From evidence to policy to implementation. Vaccine, 37(39), 5817-5824.

[15]. Markkula, J., Hemming-Harlo, M., Salminen, M. T., Savolainen-Kopra, C., Pirhonen, J., Al-Hello, H., & Vesikari, T. (2017). Rotavirus epidemiology 5–6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly. Infectious Diseases, 49(5), 388-395.

[16]. Omatola, C. A., & Olaniran, A. O. (2022). Rotaviruses: From pathogenesis to disease control—A critical review. Viruses, 14(5), 875.

[17]. Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A., & Glass, R. I. (2003). Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases, 9(5), 565.

[18]. Parashar, U. D., Nelson, E. A. S., & Kang, G. (2013). Diagnosis, management, and prevention of rotavirus gastroenteritis in children. BMJ, 347.

[19]. Sénécal, M., Brisson, M., Lebel, M. H., Yaremko, J., Wong, R., Gallant, L. A., ... & MIRAGE study group. (2008). Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study. Canadian Journal of Infectious Diseases and Medical Microbiology, 19, 397-404.

[20]. Tate, J. E., & Parashar, U. D. (2014). Rotavirus vaccines in routine use. Clinical Infectious Diseases, 59(9), 1291-1301.

If you have access to this article please login to view the article or kindly login to purchase the article

Single Article

	North Americas,UK, Middle East,Europe		India	Rest of world
	USD	EUR	INR	USD-ROW
Pdf	300
Online	300
Pdf & Online	500

ADD TO CART

Options for accessing this content:

If you would like institutional access to this content, please recommend the title to your librarian.
If you already have i-manager's user account: Login above and proceed to purchase the article.
New Users: Please register, then proceed to purchase the article.